BRD9 and leukemia: The protein Bromodomain-containing protein 9 (BRD9), a crucial part of the ncBAF variant of the SWI–SNF chromatin remodeling complex, has been identified as a potential therapeutic target in a subset of sarcomas and leukemias [79].